Xact Kapitalforvaltning’s Regenxbio RGNX Stock Holding History

Xact Kapitalforvaltning’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$230K	Hold	7,100	–	–	﹤0.01%	1149
2019 Q4	$291K	Hold	7,100	–	–	﹤0.01%	1250
2019 Q3	$253K	Hold	7,100	–	–	﹤0.01%	1290
2019 Q2	$365K	Hold	7,100	–	–	0.01%	1112
2019 Q1	$407K	Buy	+7,100	New	+$352K	0.01%	1048
2018 Q4	–	Sell	-4,600	Closed	-$347K	–	1519
2018 Q3	$347K	Hold	4,600	–	–	0.01%	1263
2018 Q2	$330K	Buy	+4,600	New	+$220K	0.01%	1263

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Xact Kapitalforvaltning's RGNX Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Regenxbio (RGNX) position steady in Q1 2020 at 7,100 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

Xact Kapitalforvaltning first reported a position in RGNX in Q2 2018 and has held it in 7 quarters since. The position peaked at $407K in Q1 2019. 170 funds tracked by Wall St. Rank hold RGNX as of Q1 2020.

Xact Kapitalforvaltning held 7,100 shares of Regenxbio worth $230K as of Q1 2020.
Xact Kapitalforvaltning left its Regenxbio share count unchanged in Q1 2020.
Regenxbio made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1149 holding.
Xact Kapitalforvaltning first reported a position in Regenxbio in Q2 2018 and has held it in 7 quarters since.
Xact Kapitalforvaltning's Regenxbio position peaked at $407K in Q1 2019.
170 funds tracked by Wall St. Rank held Regenxbio as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.